Pages

Friday, June 10, 2011

Coffee diterpenes prevent the genotoxic effects of a toxic chemical in human derived liver cell lines. - GreenMedInfo Summary

Coffee diterpenes prevent the genotoxic effects of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and N-nitrosodimethylamine in a human derived liver cell line (HepG2).
Aim of the present experiments was to study the genotoxic effects of coffee diterpenoids, namely cafestol palmitate and a mix of cafestol and kahweol (C+K) in human derived hepatoma (HepG2) cells. Furthermore, we investigated the potential protective properties of these substances towards carcinogens contained in the human diet, namely N-nitrosodimethylamine (NDMA) and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). C+K and cafestol palmitate were tested over a broad dose range in micronucleus (MN) assays and no indication for genotoxic effects was seen. In combination experiments with PhIP (300 microM), pronounced inhibition (approximately 1.7-fold) of MN formation was observed with C+K and cafestol palmitate at dose levels>or = 0.9 and 1.7 microg/ml, respectively. Enzyme measurements indicate that the protection is due to inhibition of sulfotransferase, an enzyme involved in the activation of the amine, and/or to induction of UDP-glucuronosyltransferase which detoxifies the DNA-reactive metabolites of PhIP. Furthermore, a significant increase of glutathione-S-transferase was seen, whereas the activities of cytochrome P-450 1A1 and N-acetyltransferase 1 were not significantly altered. Also in combination experiments with C+K and NDMA, strong protective effects (50% reduction of genotoxicity) were seen at low dose levels (>or = 0.3 microg/ml). Since inhibition of MN was also observed when C+K were added after incubation with NDMA, it is likely that the chemoprotective effects are due to induction of DNA repair enzymes. Comparison of data on the effects of C+K on the cholesterol metabolism, which was investigated in earlier in vivo studies, with the present findings suggests that DNA-protective effects take place at exposure levels which are substantially lower than those which cause hypercholesterolemia
Coffee diterpenes prevent the genotoxic effects of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and N-nitrosodimethylamine in a human derived liver cell line (HepG2).
Aim of the present experiments was to study the genotoxic effects of coffee diterpenoids, namely cafestol palmitate and a mix of cafestol and kahweol (C+K) in human derived hepatoma (HepG2) cells. Furthermore, we investigated the potential protective properties of these substances towards carcinogens contained in the human diet, namely N-nitrosodimethylamine (NDMA) and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). C+K and cafestol palmitate were tested over a broad dose range in micronucleus (MN) assays and no indication for genotoxic effects was seen. In combination experiments with PhIP (300 microM), pronounced inhibition (approximately 1.7-fold) of MN formation was observed with C+K and cafestol palmitate at dose levels>or = 0.9 and 1.7 microg/ml, respectively. Enzyme measurements indicate that the protection is due to inhibition of sulfotransferase, an enzyme involved in the activation of the amine, and/or to induction of UDP-glucuronosyltransferase which detoxifies the DNA-reactive metabolites of PhIP. Furthermore, a significant increase of glutathione-S-transferase was seen, whereas the activities of cytochrome P-450 1A1 and N-acetyltransferase 1 were not significantly altered. Also in combination experiments with C+K and NDMA, strong protective effects (50% reduction of genotoxicity) were seen at low dose levels (>or = 0.3 microg/ml). Since inhibition of MN was also observed when C+K were added after incubation with NDMA, it is likely that the chemoprotective effects are due to induction of DNA repair enzymes. Comparison of data on the effects of C+K on the cholesterol metabolism, which was investigated in earlier in vivo studies, with the present findings suggests that DNA-protective effects take place at exposure levels which are substantially lower than those which cause hypercholesterolemia
Read More


Tuesday, June 7, 2011

Treatment of Acute Kidney Injuries


Peritoneal Dialysis (PD) is a process used in managing acute kidney injury that is refractory to fluid therapy. PD utilizes the peritoneum as a semipermeable membrane in order to move solutes and water between blood in the peritoneal capillaries and fluid (dialysate) instilled in the peritoneal cavity. This study of the medical records of 22 cats with acute kidney injury examined the indications, effectiveness, outcomes, and complications associated with use of PD in the affected cats. Indications for peritoneal dialysis include acute-on-chronic- kidney injury, acute kidney injury caused by toxins, bilateral ureteroliths, bilateral ureteral ligation as a complication of ovariohysterectomy, and unknown causes. For all cats on PD, the median survival time was 4 days, though the median survival time for cats discharged from the hospital was 774 days. Dialysate retention and sequestration of dialysate under the skin were the most common complications noted. Results found a significant decrease between the pre-and post-dialysis results for blood urea nitrogen, creatinine, potassium, phosphorus, total protein, and albumin concentrations. PD could be used as an effective option for treatment in cats with acute kidney injury that is refractory to fluid therapy.  [VT]

Related articles:
Cooper RL, Labato MA: Peritoneal dialysis in veterinary medicine, Vet Clin North Am Small Anim Pract 41:91, 2011.

More on cat health: Winn Feline Foundation Library
Join us on Facebook
Follow us on Twitter

Peritoneal Dialysis (PD) is a process used in managing acute kidney injury that is refractory to fluid therapy. PD utilizes the peritoneum as a semipermeable membrane in order to move solutes and water between blood in the peritoneal capillaries and fluid (dialysate) instilled in the peritoneal cavity. This study of the medical records of 22 cats with acute kidney injury examined the indications, effectiveness, outcomes, and complications associated with use of PD in the affected cats. Indications for peritoneal dialysis include acute-on-chronic- kidney injury, acute kidney injury caused by toxins, bilateral ureteroliths, bilateral ureteral ligation as a complication of ovariohysterectomy, and unknown causes. For all cats on PD, the median survival time was 4 days, though the median survival time for cats discharged from the hospital was 774 days. Dialysate retention and sequestration of dialysate under the skin were the most common complications noted. Results found a significant decrease between the pre-and post-dialysis results for blood urea nitrogen, creatinine, potassium, phosphorus, total protein, and albumin concentrations. PD could be used as an effective option for treatment in cats with acute kidney injury that is refractory to fluid therapy.  [VT]

Related articles:
Cooper RL, Labato MA: Peritoneal dialysis in veterinary medicine, Vet Clin North Am Small Anim Pract 41:91, 2011.

More on cat health: Winn Feline Foundation Library
Join us on Facebook
Follow us on Twitter
Read More